| Mr Jayson Domenech Soto Sr, BSN | |
|
Hc 7 Box 99162, Arecibo, PR 00612-8727 | |
| (787) 242-7913 | |
| Not Available |
| Full Name | Mr Jayson Domenech Soto Sr |
|---|---|
| Gender | Male |
| Speciality | Registered Nurse |
| Location | Hc 7 Box 99162, Arecibo, Puerto Rico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366841215 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 32037 (Puerto Rico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Jayson Domenech Soto Sr, BSN Hc 7 Box 99162, Arecibo, PR 00612-8727 Ph: (787) 242-7913 | Mr Jayson Domenech Soto Sr, BSN Hc 7 Box 99162, Arecibo, PR 00612-8727 Ph: (787) 242-7913 |
News Archive
Oasmia Pharmaceutical AB, developer of a new generation of drugs within human and veterinary oncology, announced today the topline findings from a head-to-head comparison study of its lead human cancer product candidate Paclical and Celgene's Abraxane, which show similar pharmacokinetic (PK) profiles of the two products. The study was conducted in women with metastatic breast cancer.
VOA News examines the 2009 HIV/AIDS Implementers Meeting in Windhoek, Namibia, which recently brought together 1,500 people from 55 countries to compare notes on HIV/AIDS programs around the world. The article features comments by Assistant U.S. Global AIDS Coordinator Michele Moloney-Kitts who attended and shared some of her experiences from the meeting.
In this Atlantic opinion piece, Amanda Glassman, director of Global Health Policy at the Center for Global Development (CGD), and Denizhan Duran, a research assistant at CGD, outline the macro- and microeconomic effects non-communicable diseases (NCDs) can have on countries and families, noting that "80 percent of NCD deaths occur in developing countries, mostly the middle-income countries."
Cleara Biotech B.V., a Netherlands-based biopharmaceutical company, announced today the creation of three public-private partnerships to discover and develop new therapeutics.
The Government of Quebec's Ministère de la santé et des services sociaux has approved the addition of Revlimid(R) (lenalidomide) to the Province's Drug Formulary as a third-line therapy for multiple myeloma patients. The cost of the drug will be reimbursed under the Province's medicare system.
› Verified 6 days ago
Mr. Orlando Perez Perez, RN,BSN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: Antiguo Hospital De Distrito, Street #129, Arecibo, PR 00612 Phone: 787-878-3552 | |
Miss Karla Lorraine Diaz, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: Urb.vista Azul, Street 11 # K30, Arecibo, PR 00612 Phone: 939-279-0289 | |
Zenaida Jimenez-alameda, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: Carr.129 Assmca, Arecibo, PR 00613 Phone: 787-817-4249 Fax: 787-879-8633 | |
Francisco Otero, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: Jose Rodriguez Irizarry #152, Arecibo, PR 00612 Phone: 787-878-1548 Fax: 787-880-0832 | |
Ariam Noemi Silva Sr., NURSE Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2 Calle Thira Urb Ciudad Atlantis, Arecibo, PR 00612 Phone: 787-546-1023 | |
Mr. Aristides Arce-gonzalez, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: Carr.129 Assmca- Arecibo, Arecibo, PR 00613 Phone: 787-878-3552 Fax: 787-879-8633 |